Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Short-Term Debt repayments (2016 - 2025)

Avanos Medical (AVNS) has disclosed Short-Term Debt repayments for 7 consecutive years, with $25.0 million as the latest value for Q1 2025.

  • Quarterly Short-Term Debt repayments rose 150.0% to $25.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $25.0 million through Dec 2025, down 44.44% year-over-year, with the annual reading at $25.0 million for FY2025, 44.44% down from the prior year.
  • Short-Term Debt repayments hit $25.0 million in Q1 2025 for Avanos Medical, roughly flat from $25.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $130.0 million in Q2 2022 to a low of -$55.0 million in Q4 2021.
  • Historically, Short-Term Debt repayments has averaged $27.3 million across 5 years, with a median of $20.0 million in 2022.
  • Biggest five-year swings in Short-Term Debt repayments: crashed 1200.0% in 2021 and later surged 1200.0% in 2022.
  • Year by year, Short-Term Debt repayments stood at -$55.0 million in 2021, then surged by 136.36% to $20.0 million in 2022, then surged by 375.0% to $95.0 million in 2023, then tumbled by 73.68% to $25.0 million in 2024, then changed by 0.0% to $25.0 million in 2025.
  • Business Quant data shows Short-Term Debt repayments for AVNS at $25.0 million in Q1 2025, $25.0 million in Q4 2024, and $10.0 million in Q3 2024.